Varicella vaccination after fingolimod: A case report

Multiple Sclerosis and Related Disorders

Volumn 2, Issue 4, 2013, Pages 391-394

  Berger, Joseph R ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Fingolimod; Immunosuppression; Multiple sclerosis; Shingles; Varicella zoster vaccine; Varicella zoster virus

Indexed keywords

ACICLOVIR; FINGOLIMOD; GLATIRAMER; HERPES ZOSTER IMMUNOGLOBULIN; INTERFERON BETA SERINE; METHYLPREDNISOLONE; NATALIZUMAB; VARICELLA ZOSTER VACCINE;

ADULT; ARTICLE; CASE REPORT; CHICKENPOX; DISEASES; DRUG WITHDRAWAL; FEMALE; HERPES ZOSTER; HUMAN; IMMUNOMODULATION; MULTIPLE SCLEROSIS; RASH; SYSTEMIC ILLNESS; VACCINATION; VARICELLA ZOSTER VIRUS; VIRUS SHEDDING;

EID: 84880132858     PISSN: 22110348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.msard.2013.03.002     Document Type: Article

References (21)

1. N. Agarwal, K. Ollington, M. Kaneshiro, R. Frenck, and G.Y. Melmed Are immunosuppressive medications associated with decreased responses to routine immunizations? A systematic review Vaccine 30 2011 1413 1424
2. AM. Arvin Varicella-zoster virus: pathogenesis, immunity, and clinical management in hematopoietic cell transplant recipients Biology of Blood and Marrow Transplantation 6 2000 219 230
3. J.A. Cohen, F. Barkhof, G. Comi, HP. Hartung, BO. Khatri, and X. Montalban Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis New England Journal of Medicine 362 2010 402 415
4. P.S. Diaz, D. Au, S. Smith, M. Amylon, M. Link, and A.M. Arvin Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunization of their siblings Pediatrics 87 1991 166 170
5. Duquette P, Kappos L, Cohen JA, Francis G, Collins W, Zhang-Auberson L, et al. Long-tem safety of fingolimod in relapsing MS: phase 2 and 3 analyses. In: Proceedings of the 24th annual meeting of the consortium of multiple sclerosis centers. Montreal, Quebec; 2011.
6. Francis G, Kappos L, O'Connor P, Collins W, Zhang-Auberson L, de Vera A, et al. Lymphocytes and fingolimod - temporal pattern and relationship with infections. In: Proceedings of the 26th Congress of the European Committee for the treatment and research in multiple sclerosis. Gothenberg, Sweden; 2010.
7. L.D. Gelb Varicella-zoster virus B.N. Fields, D.M. Knipe, RM Chanock, J.L. Melnick, B. Roizman, R.E. Shope, Fields virology 1985 Raven Press New York 591 627
8. AA. Gershon Live-attenuated varicella vaccine Infectious Disease Clinics of North America 15 2001 65 81
9. S. Gourishankar, J.C. McDermid, G.S. Jhangri, and J.K. Preiksaitis Herpes zoster infection following solid organ transplantation: incidence, risk factors and outcomes in the current immunosuppressive era American Journal of Transplantation 4 2004 108 115
10. C.M. Gross, A. Baumgartner, S. Rauer, and O. Stich Multiple sclerosis rebound following herpes zoster infection and suspension of fingolimod Neurology 79 2012 2006 2007
11. R. Harpaz, I.R. Ortega-Sanchez, and J.F. Seward Prevention of herpes zoster: recommendations of the Advisory Committee on immunization practices Morbidity and Mortality Weekly Report 57 2008 1 30
12. L. Kappos, E.W. Radue, P. O'Connor, C. Polman, R. Hohlfeld, and P. Calabresi A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis New England Journal of Medicine 362 2010 387 401
13. P. LaRussa, S. Steinberg, F. Meurice, and A. Gershon Transmission of vaccine strain varicella-zoster virus from a healthy adult with vaccine-associated rash to susceptible household contacts Journal of Infectious Diseases 176 1997 1072 1075
14. A. McNulty, Y. Li, U. Radtke, J. Kaldor, R. Rohrsheim, and DA. Cooper Herpes zoster and the stage and prognosis of HIV-1 infection Genitourinary Medicine 73 1997 467 470
15. M. Mehling, V. Brinkmann, J. Antel, A. Bar-Or, N. Goebels, and C. Vedrine FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis Neurology 71 2008 1261 1267
16. D.A. Moore, and R.S. Hopkins Assessment of a school exclusion policy during a chickenpox outbreak American Journal of Epidemiology 133 1991 1161 1167
17. M.N. Oxman, M.J. Levin, G.R. Johnson, K.E. Schmader, S.E. Straus, and L.D. Gelb A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults New England Journal of Medicine 352 2005 2271 2284
18. J.N. Ratchford, K. Costello, D.S. Reich, and P.A. Calabresi Varicella-zoster virus encephalitis and vasculopathy in a patient treated with fingolimod Neurology 79 2012 2002 2004
19. J.J. Rusthoven, P. Ahlgren, T. Elhakim, P. Pinfold, J. Reid, and L. Stewart Varicella-zoster infection in adult cancer patients. A population study Archives of Internal Medicine 148 1988 1561 1566
20. M.B. Salzman, R.G. Sharrar, S. Steinberg, and P. LaRussa Transmission of varicella-vaccine virus from a healthy 12-month-old child to his pregnant mother Journal of Pediatrics 131 1997 151 154
21. H.F. Tseng, M. Chi, N. Smith, S.M. Marcy, L.S. Sy, and S.J. Jacobsen Herpes zoster vaccine and the incidence of recurrent herpes zoster in an immunocompetent elderly population Journal of Infectious Diseases 206 2012 190 196